No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers
podcast MM&M Partner Perspectives
- Language: eng
- Published: 27 Jul 2016
- Duration: 10:38
Marc Iskowitz, MM&M's editor in chief, discusses a qualitative/quantitative approach to meeting orphan drug marketers' engagement challenge with Michael Carlin, vice president at TrialCard.